ADAMTS16 DNA methylation has been shown to be dysregulated in several epithelial cancers, including lung cancer (35), suggesting that regulation of ADAMTS16 protein expression in tumour-associated ECM, and its potential as a protein biomarker in NSCLC, warrant investigation. This evidence concerns the gene ADAMTS16 and lung carcinoma.